Vertical: CNMBase Year: 2025
Market Size (2025)
$26.08M
Projected (2032)
$38.78M
CAGR (2022–2032)
5.9%
Key Players
9+
Market Overview
The global lambda-cyhalothric acid market was valued at USD 26.079 Million in 2025 and is projected to reach USD 38.778 Million by 2032, registering a CAGR of 5.82% during 2026–2032. The market expanded from USD 21.919 Million in 2022, and the forecast implies an absolute increase of USD 12.699 Million between 2025 and 2032. Lambda-cyhalothric acid, the (Z)-cis cyclopropanecarboxylic acid that forms the acid moiety of lambda-cyhalothrin and of several related pyrethroids, is a captive and merchant intermediate whose demand is governed by the production of technical-grade insecticides rather than by direct end-use consumption.
Demand is anchored in the global crop protection industry, where lambda-cyhalothrin remains one of the most widely used broad-spectrum pyrethroid insecticides in cotton, rice, maize, soybean, vegetables and fruit, as well as in public health vector control. Production of the acid is concentrated in China, with growing backward-integration activity in India, and both countries supply technical-grade pyrethroids to formulators in Latin America, North America, Europe, Africa and the rest of Asia. The market is therefore shaped by technical-grade pyrethroid capacity additions, environmental and safety enforcement at chemical parks, generic price cycles and regulatory decisions on pyrethroid registrations in major agricultural markets.
Key Findings
Downstream Product: Lambda-Cyhalothrin is the largest segment, accounting for 85.0% of the market in 2025 (USD 22.167 Million). The Others segment is the fastest-growing, with a CAGR of 7.19% during 2026–2032.
Purity: The 98% & Above segment is both the largest and the fastest-growing purity segment, holding 80.0% of the market in 2025 (USD 20.863 Million) and expanding at a CAGR of 6.29%.
Region: Asia Pacific is the leading region with a 78.0% share in 2025 (USD 20.342 Million), while Middle East & Africa is the fastest-growing region with a CAGR of 8.63%.
Country: China is the leading country market, valued at USD 11.147 Million in 2025 (42.7% of the global market). UAE is the fastest-growing country, with a CAGR of 10.24% during 2026–2032.
Absolute growth: The global market is expected to add USD 12.699 Million between 2025 and 2032, of which Asia Pacific contributes USD 10.099 Million.
Segmentation Summary
The market is analysed by downstream product and by purity. By downstream product, Lambda-Cyhalothrin dominates because lambda-cyhalothrin technical is the principal derivative manufactured from the acid; the segment is projected to grow from USD 22.167 Million in 2025 to USD 32.418 Million by 2032, registering a CAGR of 5.56% during 2026–2032. The Others segment, which covers the remaining pyrethroids synthesised from the same acid intermediate, is projected to grow from USD 3.912 Million in 2025 to USD 6.360 Million by 2032, registering a CAGR of 7.19% during 2026–2032, outpacing the larger segment as derivative portfolios broaden.
By purity, the 98% & Above segment accounted for USD 20.863 Million in 2025 and is projected to reach USD 31.992 Million by 2032 at a CAGR of 6.29%. The Below 98% segment is projected to grow from USD 5.216 Million to USD 6.786 Million at a CAGR of 3.76%. The faster growth of high-purity material reflects tighter isomer and impurity specifications for technical-grade actives destined for regulated markets.
Competitive Landscape Summary
The market is moderately consolidated at the intermediate stage and more fragmented at the technical-grade stage. Jiangsu Yangnong Chemical Co., Ltd., controlled by Syngenta Group, operates an integrated chain from pyrethroid key intermediates to lambda-cyhalothrin and bifenthrin technicals and is the most prominent integrated producer. Indian companies, including Meghmani Organics, Heranba Industries, Bharat Rasayan, Tagros Chemicals India and Dhanuka Agritech, are expanding lambda-cyhalothrin and bifenthrin technical capacity and pursuing backward integration into intermediates. Multinational brand owners such as Syngenta Group and FMC Corporation shape demand through branded formulations and sourcing decisions. Competition centres on cost of production, isomer purity, regulatory dossiers and security of upstream supply.
Challenges and Opportunities
The principal challenges are the complex, multi-step synthesis of the acid, which involves hazardous reagents and fluorinated building blocks; stringent environmental and safety enforcement in Chinese chemical parks; volatile prices of upstream precursors; and regulatory pressure on pyrethroids in Europe and North America over aquatic toxicity and effects on non-target organisms. Upstream disruptions remain material: an October 2025 safety incident at a Chinese supplier of methyl 3,3-dimethyl-4-pentenoate, a precursor of cyhalothric acid, tightened supply and lifted prices of pyrethroid intermediates and technicals.
Opportunities lie in backward integration by Indian and Chinese technical producers, rising demand for high-purity acid for regulated-market technicals, faster growth of insecticide consumption in Latin America, the Middle East and Africa, and continued use of lambda-cyhalothrin in vector control programmes. Supply diversification by global formulators away from single-country sourcing also supports new capacity outside the established Chinese clusters.
Future Outlook
Between 2026 and 2032, the market is projected to grow steadily at a CAGR of 5.82%, reaching USD 38.778 Million by 2032. Asia Pacific will remain the production and consumption centre, with China projected to reach USD 15.921 Million and India USD 8.371 Million by 2032. Growth rates will be highest in Middle East & Africa (8.63%) and Latin America (7.75%), while North America (3.91%) and Europe (3.76%) will grow more slowly due to mature crop protection markets and regulatory constraints. Over the forecast period, integration, purity upgrades and supply security are expected to remain the main competitive levers.
The Lambda-Cyhalothric Acid Market market is projected to grow at a CAGR of 5.9% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Lambda-cyhalothric acid (CAS No. 72748-35-7) is the (Z)-cis isomer of 3-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-2,2-dimethylcyclopropanecarboxylic acid. It is a halogenated cyclopropanecarboxylic acid that forms the acid half of the ester in lambda-cyhalothrin and in other pyrethroid insecticides built on the same acid. In commercial practice, the acid is converted to its acid chloride and esterified with the corresponding alcohol or cyanohydrin; for lambda-cyhalothrin, this is α-cyano-3-phenoxybenzyl alcohol derived from 3-phenoxybenzaldehyde. The stereochemistry of the acid, particularly the Z-configuration of the double bond and the cis-configuration of the cyclopropane ring, determines the insecticidal activity and the isomer profile of the final technical product.
The scope of this study includes lambda-cyhalothric acid produced for captive conversion and for merchant sale, in all purity grades, consumed in the manufacture of lambda-cyhalothrin technical and other downstream pyrethroid products. Market value is measured at the intermediate level. The study excludes the value of downstream technical-grade active ingredients and formulated products, other pyrethroid acids such as cypermethric (permethric) acid and chrysanthemic acid, and the alcohol-side intermediates such as 3-phenoxybenzaldehyde.
Research Objectives
To estimate the size of the global lambda-cyhalothric acid market for the historic years 2022–2024 and the base year 2025, and to forecast it for 2026–2032 in USD Million.
To analyse the market by downstream product (Lambda-Cyhalothrin and Others) and by purity (98% & Above and Below 98%).
To assess the market across North America, Europe, Asia Pacific, Latin America and Middle East & Africa, and across the key countries within each region.
To identify the drivers, restraints, opportunities, trends and challenges influencing demand for lambda-cyhalothric acid and its pyrethroid derivatives.
To evaluate the value chain from fluorinated and cyclopropane precursors through acid synthesis, technical-grade conversion and formulation.
To review the regulatory frameworks for pyrethroid registration, residue limits and chemical manufacturing in major producing and consuming regions.
To profile the competitive environment, including positioning, integration levels and key developments of leading acid and pyrethroid technical producers since 2022.
To provide a forward-looking view of supply security, purity requirements and capacity investment through 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured research process combining secondary research, primary research, market size estimation, data triangulation and forecasting. The process began with defining the market boundaries for lambda-cyhalothric acid at the intermediate level and mapping the conversion routes to lambda-cyhalothrin and other downstream pyrethroids. Secondary research established the supply base, technical-grade production volumes, trade flows and regulatory status. Primary research validated these findings with participants across the value chain. Market estimates were then built using top-down and bottom-up approaches, reconciled through triangulation, and projected over the forecast period using a factor-based model.
Secondary Research
Secondary research covered the following source types relevant to the pyrethroid intermediates industry:
Industry associations: crop protection and pesticide manufacturer associations in China, India, Europe and the Americas, including publications on pyrethroid production and generic active ingredient trade.
Government and regulatory bodies: pesticide registration authorities (such as the U.S. EPA, the European Commission and EFSA, India's Central Insecticides Board & Registration Committee, China's ICAMA and Brazil's MAPA), environmental clearance records, and customs and trade statistics for cyclanic carboxylic acids and their derivatives.
Company filings: annual reports, stock exchange filings, investor presentations, credit rating reports and environmental clearance documents of acid and technical-grade producers.
Trade journals and industry media: agrochemical trade publications and chemical industry news covering capacity additions, pricing and supply disruptions.
Paid databases: trade databases, chemical price reporting services and company information databases.
Primary Research
Primary research was conducted through in-depth interviews with industry participants on both the supply and demand sides. Supply-side respondents included production and business heads at acid and pyrethroid technical manufacturers, suppliers of fluorinated and cyclopropane precursors, and traders of agrochemical intermediates. Demand-side respondents included procurement and technical managers at formulators, distributors and multinational crop protection companies, as well as agronomy and vector-control specialists.
The objectives of the primary research were to validate secondary estimates of production and consumption, understand captive versus merchant supply, assess purity and isomer specifications, identify pricing trends and supply risks, and gather views on growth prospects by region and downstream product.
Market Size Estimation
Top-down approach: The global market for lambda-cyhalothrin and other downstream pyrethroids built on the same acid was estimated and converted into acid demand using stoichiometric consumption ratios and process yields, then valued using prevailing acid prices.
Bottom-up approach: Acid production and captive consumption were estimated for individual producers and countries using reported capacities, utilisation rates and technical-grade output, and then aggregated to regional and global totals.
Data triangulation: The results of the two approaches were reconciled with trade data, company disclosures and primary interview inputs. Differences were resolved by weighting the most reliable data points, and the final estimates were split by downstream product, purity, region and country.
Forecasting Methodology
The forecast was developed by projecting downstream demand for lambda-cyhalothrin and other derivative pyrethroids and translating it into acid demand. Factors considered include insecticide consumption trends by crop and region, planted area and pest pressure, adoption of generic pyrethroids, regulatory changes affecting registrations, capacity additions and closures, purity and isomer specification trends, raw material availability, and macroeconomic indicators such as agricultural GDP and farm incomes. Growth rates were set for each region and segment, cross-checked against primary research, and expressed as CAGR for 2026–2032.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024
Base year: 2025
Forecast period: 2026–2032
CAGR period: 2026–2032
Currency: USD Million (values at current prices)
Assumptions and Limitations
Market value is measured at the intermediate level and includes both captive and merchant volumes valued at equivalent market prices.
Exchange rates are assumed to remain broadly stable over the forecast period.
No major regulatory ban on lambda-cyhalothrin is assumed in the principal consuming markets during 2026–2032.
Capacity data for privately held Chinese and Indian producers is limited, and some volumes are estimated from technical-grade output and environmental clearance records.
Short-term price spikes caused by plant shutdowns or upstream incidents are smoothed in the forecast.
Regional and country values are derived from downstream pyrethroid production and consumption attributable to each geography.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The lambda-cyhalothric acid market is moderately consolidated at the intermediate stage. Production of the acid requires specialised stereoselective synthesis, access to fluorinated and cyclopropane precursors, and environmental permits in approved chemical parks, which restricts the number of active producers. Much of the acid is produced captively by integrated pyrethroid manufacturers and converted in-house to technical-grade lambda-cyhalothrin and bifenthrin, so merchant trade represents a smaller part of total volume.
Several Chinese acid producers were shut following safety and environmental enforcement in Jiangsu in 2019, which increased the importance of integrated producers that kept operating. At the technical-grade stage, the market is more fragmented, with a group of Chinese and Indian producers competing on cost, purity, registration support and reliability of supply. Multinational crop protection companies influence the market as originators, brand owners and buyers of technicals. Competition is based mainly on production cost, integration depth, isomer purity, regulatory dossiers and the ability to secure upstream raw materials.
Key Player Positioning
Leaders: Jiangsu Yangnong Chemical Co., Ltd. is the leading integrated producer. It describes itself as China's largest pyrethroid producer, states that its pyrethroid key intermediates are self-contained, and manufactures lambda-cyhalothrin and bifenthrin technicals. It reported operating revenue of RMB 11.87 billion for FY2025 and is expanding through its Huludao site in Liaoning. Syngenta Group, the originator of lambda-cyhalothrin and owner of the Karate brand, is Yangnong's controlling shareholder (35.94%) and reported group sales of USD 28.4 billion in FY2025, giving it influence over both supply and demand of the acid.
Challengers: Indian producers Meghmani Organics (FY2026 consolidated revenue from operations of INR 2,173.9 crore), Heranba Industries (INR 1,594.99 crore), Bharat Rasayan (FY2026 standalone revenue from operations of INR 1,241.84 crore) and Tagros Chemicals India are established lambda-cyhalothrin technical producers with export-oriented portfolios and integration into pyrethroid intermediates. Meghmani describes itself as a leading manufacturer and exporter of lambda-cyhalothrin technical, Bharat Rasayan holds a leading position in lambda-cyhalothrin technical and in 3-phenoxybenzaldehyde, and Tagros holds WHO prequalification for lambda-cyhalothrin technical.
Niche and emerging players: Dhanuka Agritech (FY2026 revenue from operations of INR 2,019.79 crore) is building backward integration at Dahej, where its environmental clearance covers lambda-cyhalothric acid, lambda-cyhalothrin and bifenthrin. Guangdong Liwei Chemical is a privately held Chinese producer of lambda-cyhalothrin and bifenthrin technicals. FMC Corporation (FY2025 revenue of USD 3,467.4 million) is a major brand owner of bifenthrin and gamma-cyhalothrin products that sources key intermediates and finished products from suppliers in China and India, and its sourcing decisions influence demand for acid-based technicals.
Competitor Dashboard
The dashboard below rates the profiled companies on four qualitative parameters on a scale of Low, Medium, High and Very High.
Threat of New Entrants: Low
Multi-step synthesis with stereochemical control requires specialised process know-how.
Environmental clearances, safety permits and location within approved chemical parks impose long lead times and high capital costs.
Integrated incumbents benefit from scale and captive offtake.
Bargaining Power of Suppliers: Medium
Key precursors are produced by a limited number of Chinese suppliers, and incidents can tighten supply quickly.
Integrated producers reduce supplier power by producing precursors in-house.
Bargaining Power of Buyers: Medium
Large technical-grade producers and multinational brand owners negotiate long-term contracts and qualify multiple sources.
Purity and dossier-equivalence requirements limit the ability of buyers to switch suppliers quickly.
Threat of Substitutes: Medium
Alternative insecticide classes such as diamides, neonicotinoids and newer chemistries compete with lambda-cyhalothrin in many crops.
Pyrethroids retain a strong cost-per-hectare advantage and a role as mixture partners, limiting substitution.
Biological insecticides are gaining share in some high-value crops.
Intensity of Competitive Rivalry: High
The downstream products are mature generics, and competition is driven by cost and price.
Capacity additions in China and India periodically create oversupply.
Producers compete on purity, reliability of supply and regulatory support.
Threat of New Entrants: Low.
Bargaining Power of Suppliers: Medium.
Bargaining Power of Buyers: Medium.
Threat of Substitutes: Medium.
Intensity of Competitive Rivalry: High.
Market estimates by geography (2032)
InsightAsia Pacific leads with $30.44M by 2032, while Middle East & Africa is projected to grow fastest at a 8.4% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $1.40M | $1.70M | $2.06M | 3.9% | 5% |
| Europe | $1.89M | $2.27M | $2.71M | 3.7% | 7% |
| Asia Pacific | $16.99M | $22.85M | $30.44M | 6.0% | 78% |
| Latin America | $1.23M | $1.81M | $2.64M | 7.9% | 7% |
| Middle East & Africa | $0.42M | $0.61M | $0.93M | 8.4% | 2% |
| Total | $21.92M | $29.25M | $38.78M | 5.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$38.78M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Lambda-Cyhalothrin | $32.42M | 5.6% | 84% |
| Others | $6.36M | 7.3% | 16% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Lambda-Cyhalothric Acid Market covering market dynamics, competitive landscape, and strategic outlook.
The Lambda-Cyhalothric Acid Market market is projected to reach $38.78M by 2032, growing at 5.9% CAGR. The Lambda-Cyhalothrin segment holds the largest share.
Demand for lambda-cyhalothric acid follows the production cycle of lambda-cyhalothrin and related pyrethroids. The market grew from USD 21.919 Million in 2022 to USD 26.079 Million in 2025 and is projected to grow at a CAGR of 5.82% through 2032. This chapter examines the macro and micro factors that influence the market, followed by drivers, restraints, opportunities, and key trends and challenges. The impact scores in the growth factor analysis are analyst assessments on a scale of 1 to 10, where a higher score indicates a stronger influence on the market in the period shown.
Sustained Demand for Lambda-Cyhalothrin in Row Crops and Horticulture
Lambda-cyhalothrin is among the most widely used pyrethroid insecticides worldwide. It is valued for its broad spectrum, fast knockdown, low application rates and low cost per hectare, which make it a standard tool against lepidopteran pests, aphids, thrips and beetles in cotton, rice, maize, soybean, wheat, pulses, vegetables and fruit. Its off-patent status has enabled a large generic supply base, and it is widely registered in solo and mixture products, including combinations with neonicotinoids, diamides and organophosphates. Expansion of planted area and intensification of insect control in Brazil, Argentina, India, Southeast Asia and Africa sustain demand for the technical-grade active and, in turn, for the acid intermediate. Because the acid represents the more complex and higher-value half of the lambda-cyhalothrin molecule, every increase in technical-grade output translates directly into acid demand. This underpins the Lambda-Cyhalothrin segment, which accounted for USD 22.167 Million in 2025 and is projected to reach USD 32.418 Million by 2032.
Broadening Portfolio of Pyrethroids Built on the Same Acid
The same cyclopropane acid scaffold is used for other commercially important pyrethroids, including gamma-cyhalothrin (a single-isomer product), bifenthrin and tefluthrin. Bifenthrin is used in soil and foliar applications in row crops, in termite and structural pest control, and in turf and ornamental markets, while tefluthrin is a soil insecticide used in maize and sugar beet. Producers have been adding bifenthrin capacity: Meghmani Organics raised its bifenthrin technical capacity to 5,000 MT per annum in October 2025, citing registrations in Brazil, Mexico and Argentina, and Dhanuka Agritech started its Dahej technical plant with bifenthrin as its first product. These additions support the Others segment, which is projected to grow at a CAGR of 7.19% from 2026 to 2032, faster than the overall market.
Capacity Investment and Backward Integration in China and India
Technical-grade producers are investing to secure the acid in-house. Jiangsu Yangnong Chemical states that its pyrethroid key intermediates are self-contained, and its RMB 4.238 billion Huludao project in Liaoning, which includes lambda-cyhalothrin among its products and 7,000 t/yr of intermediates, entered commissioning in 2025. In India, environmental clearance for Dhanuka Agritech's Dahej plant covers lambda-cyhalothric acid alongside lambda-cyhalothrin and bifenthrin, while Meghmani Organics, Heranba Industries and Bharat Rasayan have expanded pyrethroid technical capacity in Gujarat. Global crop protection companies seeking to diversify supply away from a single country have reinforced this investment trend. Backward integration converts merchant demand into captive demand but increases the total volume of acid produced, as producers seek cost control and supply security over the full chain.
Public Health and Vector Control Applications
Lambda-cyhalothrin is used in indoor residual spraying, space spraying and treated materials for the control of mosquitoes and other disease vectors. Products used in public health programmes are subject to WHO prequalification, and lambda-cyhalothrin technical from producers such as Tagros Chemicals India appears on the WHO prequalified list for vector control products. Procurement by national malaria and dengue control programmes, supported by international donors, provides a stable base of demand that is less exposed to agricultural commodity cycles. Although resistance management programmes rotate insecticide classes, pyrethroids remain a core tool, which supports steady consumption of the acid in tropical regions of Asia, Africa and Latin America.
Growth in High-Purity Acid for Regulated-Market Technicals
Registration authorities require technical-grade actives to meet specifications for isomer ratio and relevant impurities that match the reference dossier. Producers supplying technicals to the United States, Europe, Brazil and other regulated markets therefore need acid of consistently high stereochemical purity. The 98% & Above segment is projected to grow from USD 20.863 Million in 2025 to USD 31.992 Million by 2032, registering a CAGR of 6.29% during 2026–2032, offering producers with strong process control an opportunity to command premium pricing.
Rising Insecticide Demand in Latin America, the Middle East and Africa
Latin America and Middle East & Africa are the fastest-growing regions, with CAGRs of 7.75% and 8.63% respectively. Expansion of soybean, maize and cotton in Brazil and Argentina, and of horticulture and staple crops in Africa and the Gulf, increases demand for cost-effective pyrethroids. Producers with registrations and distribution in these markets can capture faster-than-average growth.
Supply Diversification and Contract Manufacturing
Supply interruptions, such as the October 2025 incident at a Chinese supplier of a key acid precursor, have reinforced the interest of multinational and generic formulators in qualifying additional sources. This creates opportunities for Indian and other non-Chinese producers to supply acid and technicals under long-term contracts, and for integrated producers to offer secure supply to brand owners that outsource manufacturing.
Regulatory Pressure on Pyrethroids in Developed Markets
Pyrethroids are highly toxic to fish, aquatic invertebrates and bees, and regulators in developed markets apply strict risk mitigation. In the European Union, lambda-cyhalothrin is listed as a candidate for substitution under Regulation (EC) No 1107/2009, and the approval of bifenthrin was not renewed in 2019. In the United States, pyrethroids are subject to EPA registration review with label mitigation for aquatic and pollinator risk. These measures limit volume growth in North America and Europe, which grow at CAGRs of 3.91% and 3.76% respectively, the lowest among all regions.
Complex Synthesis and Environmental Compliance Costs
Synthesis of the acid involves multiple steps, fluorinated reagents and hazardous intermediates, and generates waste streams that require treatment. Following safety incidents in Jiangsu in 2019, several Chinese producers of cyhalothric acid were shut, and enforcement of chemical park standards has continued. The resulting compliance costs, permit timelines and risk of forced shutdowns raise barriers to entry and constrain supply flexibility.
Generic Price Competition and Inventory Cycles
Lambda-cyhalothrin is a mature generic, and prices of technical-grade pyrethroids are highly sensitive to Chinese supply and to channel inventory. The destocking cycle in the global crop protection market during 2023 and 2024 depressed prices and volumes, which compressed margins across the chain and delayed some investment decisions.
Integration from Precursors to Technicals
Leading producers are integrating from cyclopropane and fluorinated precursors to acid chloride and technical-grade actives. Integration improves cost position and reduces exposure to merchant price spikes, and integrated players were reported to be better placed to absorb the precursor shortage in late 2025.
Price Volatility in the Pyrethroid Chain
Pyrethroid prices have become more volatile. Industry price reporting indicated a rise in lambda-cyhalothrin and bifenthrin prices in the first half of 2026 after the late-2025 precursor shortage, with lambda-cyhalothrin quoted at about RMB 105,000 per tonne in China in August 2026. Volatility complicates contract pricing between acid producers and technical manufacturers.
Insecticide Resistance Management
Resistance to pyrethroids in key pests and in malaria vectors is a long-term challenge. It encourages the use of mixtures and rotation with other modes of action, which can limit the use of solo pyrethroid products but also sustains demand for pyrethroids as mixture partners.
Relocation and Consolidation of Chinese Capacity
Chinese pesticide production continues to relocate into approved chemical parks and to consolidate around larger producers. New capacity, such as Yangnong's Huludao site in northern China, reflects this trend, while smaller producers exit. The shift improves safety and environmental performance but reduces the number of suppliers in the market.
The lambda-cyhalothric acid value chain comprises four stages:
Raw materials and inputs: Key inputs include 3,3-dimethyl-4-pentenoate esters (such as methyl 3,3-dimethyl-4-pentenoate), fluorinated and chlorinated building blocks used to introduce the 2-chloro-3,3,3-trifluoropropenyl group, solvents, bases and catalysts. Supply of these precursors is concentrated in China, and disruptions at individual suppliers can affect acid availability across the market.
Manufacturing: The acid is produced by multi-step synthesis involving addition, cyclisation, dehydrohalogenation and isomer separation or enrichment to obtain the (Z)-cis acid, which is then converted to the acid chloride. Manufacturing is either captive within integrated pyrethroid producers or conducted by specialised intermediate producers for merchant sale.
Distribution and channels: Most acid moves within integrated producers or through direct supply contracts between acid producers and technical-grade manufacturers. Merchant volumes are traded through chemical distributors and export traders, mainly from China to India and other producing countries.
End users: The acid is consumed by manufacturers of lambda-cyhalothrin, gamma-cyhalothrin, bifenthrin and tefluthrin technicals. Their products are sold to formulators and brand owners, who supply farmers, public health programmes and professional pest control operators.
Oct–Dec 2022: Meghmani Organics; Expansion; Commissioned a 5,000 MTPA multi-purpose plant at Dahej, Gujarat, with capital expenditure of INR 390 crore; lambda-cyhalothrin technical is among its major products.
Nov 2022: Heranba Industries; Expansion; Commissioned Unit 4 at Vapi and continued capital expenditure at Sarigam for technicals and intermediates.
Mar 2023: Tagros Chemicals India; Expansion; Received environmental clearance from MoEFCC to expand technical and intermediate production at SIPCOT Panchayankuppam, Cuddalore, Tamil Nadu.
2023: Dhanuka Agritech; Expansion; Commenced operations at its greenfield technical manufacturing plant at Dahej (about INR 267 crore investment), with bifenthrin technical as the first product.
Oct 2023: Jiangsu Yangnong Chemical; Expansion; Completed environmental impact disclosure for the Huludao, Liaoning project of subsidiary Liaoning Youchuang (22,650 t/yr total capacity, including lambda-cyhalothrin and 7,000 t/yr of intermediates; investment of RMB 4.238 billion).
Feb 2024: Bharat Rasayan; Expansion; Restarted Block D at its Dahej plant after reconstruction following a fire; the block reached full capacity by December 2024.
Nov 2024: FMC Corporation; Divestment; Completed the sale of its Global Specialty Solutions business, including the Talstar bifenthrin brand, to Envu for about USD 340 million.
Apr 2025: Heranba Industries; Expansion; Subsidiary Heranba Organics began commercial production at Saykha Phase I (about 6,000 MTPA).
H1 2025: Jiangsu Yangnong Chemical; Expansion; Phase 1, stage 1 of the Huludao project entered commissioning, with commissioned products reaching design capacity.
Jun 2025: Heranba Industries; Expansion; Began commercial production at Sarigam Phase II for insecticides and fungicides.
Oct 2025: Meghmani Organics; Expansion; Increased bifenthrin technical capacity to 5,000 MT per annum, citing registrations in Brazil, Mexico and Argentina.
Jan 2026: Syngenta Group; Expansion; Opened a new crop protection formulation plant in Nantong, China.
Jan 2026: Tagros Chemicals India; Acquisition; Agreed to acquire Bayer's flubendiamide formulations business outside India, covering more than 25 countries.
Mar 2026: Jiangsu Yangnong Chemical; Expansion; Reported that the Huludao site turned profitable in 2025 and that Phase 2 construction was completed ahead of schedule.
May 2026: Dhanuka Agritech; Expansion; Board approved the formation or acquisition of subsidiaries in Brazil and Europe.
Jul 2026: FMC Corporation; Partnership; Agreed to a USD 400 million minority equity investment from Tessenderlo Group for a stake of about 20%, subject to regulatory approval.
Political
Government support for agricultural productivity and food security sustains insecticide demand in Asia, Latin America and Africa.
Trade policies, export controls and tariffs affect the flow of intermediates and technicals between China, India and consuming markets.
Industrial policies in India that promote domestic chemical manufacturing support investment in backward integration.
Economic
Agricultural commodity prices and farm incomes influence insecticide spending.
Generic price competition and inventory cycles drive volatility in pyrethroid and acid prices.
Costs of energy, fluorinated inputs and environmental compliance affect producer margins.
Social
Public concern over pesticide residues and pollinator health shapes regulation and retailer standards in developed markets.
Vector-borne diseases such as malaria and dengue sustain public health demand for pyrethroids.
Technological
Process improvements in stereoselective synthesis and isomer enrichment increase the yield of the active (Z)-cis acid.
Formulation technologies such as capsule suspensions extend the residual activity and safety profile of lambda-cyhalothrin products.
Continuous processing and waste reduction technologies lower environmental footprints.
Environmental
High aquatic toxicity of pyrethroids leads to buffer zones and use restrictions.
Effluent treatment and emission standards in chemical parks raise production costs.
Industrial accidents can trigger regional shutdowns and supply disruptions.
Legal
Registration renewals and data requirements govern market access for downstream products.
Maximum residue limits in importing countries affect pyrethroid use on export crops.
Patent and data protection disputes over pyrethroid mixtures can affect generic product launches.
Profiles of 106 companies operating in the Lambda-Cyhalothric Acid Market market, including revenue, employee count, and market positioning where available.
Showing 106 of 106 companies
FMC Corporation is a Philadelphia-based, pure-play crop-protection company and one of the tier-one research-based agrochemical innovators, alongside Syngenta, Bayer, BASF and Corteva. It discovers, develops, manufactures and markets insecticides, herbicides, fungicides and "Plant Health" products (biologicals, crop nutrition, seed treatment) through distributors, retailers, cooperatives and, increasingly, direct-to-grower channels in Brazil. Its economic franchise was built on the diamide insecticides acquired from DuPont in 2017: Rynaxypyr® (~USD 0.8bn of FY2025 sales) and Cyazypyr® (~USD 0.4bn). Both have now lost core patent protection. FMC is therefore in a deep transition. FY2025 revenue fell to USD 3.47bn and the company booked a USD 2.24bn GAAP loss. It has cut the dividend 86%, fallen to junk credit status, and in 2026 raised capital through asset sales, a Corteva licence and a 20% equity stake sale to Tessenderlo Group. The equity case now rests on four new-mode-of-action active ingredients: Isoflex®, fluindapyr, Dodhylex™ and rimisoxafen. --- ### Company's own description (FY2025 10-K, paraphrased) FMC describes itself as a global agricultural sciences company that supplies farmers with innovative solutions to increase the productivity and resilience of their land, and states that it operates in a single business segment. It develops, markets and sells all three major classes of crop-protection chemicals (insecticides, herbicides and fungicides), together with biologicals, crop nutrition and seed-treatment products grouped as "Plant Health." The 10-K calls FMC a "tier-one leader" in agrochemicals, positioned through technology, geographic balance and crop diversity. For 2026 it sets four operational priorities: - strengthening the balance sheet; - improving competitiveness of the core portfolio; - managing the post-patent Rynaxypyr® transition; - supporting the growth of new active ingredients. ### Value-chain position FMC is a discovery-to-formulation innovator that relies heavily on outsourcing. It owns large-scale AI plants in: - Mobile, Alabama (USA) - Manati, Puerto Rico - Jinshan, China - Rønland, Denmark - Panoli, India It also sources "critical intermediates and finished products" largely from third parties in China and India (10-K FY2025 risk factors). Downstream, it sells through: - distributors, retailers and cooperatives in all four regions; - direct sales to large growers in Brazil, an expanding channel cited as a Q4 FY2026 growth driver; - alliance partners, including diamide partners on "cost-plus" contracts. ### Customer types and end-markets Customers are agricultural distributors and retailers, co-ops, large growers (Brazil), and other agrochemical companies that buy diamide AI under supply contracts. End-markets are row crops (soybean, corn, cotton, sugarcane, rice, cereals) and specialty crops (fruits, vegetables, tree nuts). Non-crop uses (pest control, turf) were largely exited with the sale of the Global Specialty Solutions business in November 2024. Demand is seasonal. Northern-hemisphere demand runs March–September, weighting Q1/Q2. Southern-hemisphere demand runs July–February, weighting Q3, Q4 and Q1 (10-K FY2025). ### Independent characterization FMC is a mid-sized research-based agrochemical company. It has a disproportionately concentrated franchise: the diamides were roughly 35% of FY2025 GAAP revenue (USD ~1.2bn of USD 3.47bn). The company is now caught between generic-driven price deflation on its legacy molecules and a still-sub-scale new-AI portfolio (USD ~200M in FY2025). It also faces an unusually leveraged balance sheet for a company of its size. Its strategy has shifted from "growth and returns" (2021–2023) to "survival and re-base" (2025–2026): - monetize IP through partners (Corteva); - shrink the manufacturing footprint (Project Foundation); - exit structurally unprofitable markets (India commercial); - recapitalize via a strategic minority investor (Tessenderlo).
Meghmani Organics Limited is an Ahmedabad-based, export-led, backward-integrated specialty and agro-chemicals manufacturer controlled by the second generation of the Patel–Soparkar founding families. Its economic engine is Crop Protection (~78% of FY26 standalone revenue), where it is among India's top-10 pesticide manufacturers, spanning intermediates, technicals and 40+ branded formulations, with a pyrethroid and 2,4-D herbicide franchise sold into Brazil, the US, Africa, Latin America and Europe. Its second pillar, Pigments (~22%), positions it among the top three global phthalocyanine pigment producers with an ~8% share and the largest CPC-blue producer. Two adjacencies — liquid nano-fertilisers (Meghmani Crop Nutrition) and titanium dioxide (Kilburn Chemicals, currently suspended) — represent its diversification bets, both being folded into the parent through a pending amalgamation. About 85% of revenue is exported to 75+ countries. The investment case today is a margin-recovery and deleveraging story in a cyclical, tariff-exposed industry. --- ### Company's own description In its latest disclosures (Q4 FY26 press release, 14 May 2026; Q1 FY27 press release, 29 July 2026), the company describes itself as "a fully integrated diversified chemical company with presence in Crop Protection, Crop Nutrition and Pigments." It states that it is amongst the top three global phthalocyanine-based pigment players with an 8% market share and amongst the top-10 manufacturers of pesticides in India with a presence across the entire value chain; that it has 40+ brands of pesticide formulations in India and a 400+ customer base across diverse industries; that it has a global presence in 75+ countries with a distribution network of 3,500+ distributors and dealers across India; and that ~85% of its topline comes from export markets (FY26). ### What the company does — independent characterisation MOL is fundamentally a B2B batch-chemistry manufacturer whose competitive identity rests on three attributes: 1. **Backward integration.** In agrochemicals it produces key pyrethroid intermediates in-house — cypermethric acid chloride (CMAC), meta-phenoxy benzaldehyde (MPBD) and meta-phenoxy benzyl alcohol (MPBAL) — which CRISIL (Apr 2026) credits with reducing import dependence and conferring a cost advantage. In pigments it is backward-integrated into crude copper phthalocyanine (CPC) blue, the base for Pigment Blue 15-series and Pigment Green 7/36. 2. **Off-patent, generic-molecule exposure.** The crop-protection portfolio is predominantly mature generic molecules (synthetic pyrethroid insecticides, 2,4-D herbicide) sold as technicals to global formulators/distributors and as branded formulations domestically. Value creation therefore depends on registrations (788 product registrations in FY25 vs 693 in FY23, per company disclosures summarised by Screener), cost position and capacity utilisation, rather than proprietary IP. 3. **Export dependence.** ~85% export share (FY26) versus ~80% (FY24) makes MOL highly exposed to US tariffs, Brazilian demand cycles, Chinese pricing and global channel inventory cycles. Management has historically noted that ~45% of crop-protection demand comes from the US and Brazil (investor presentations, Nov 2023 and May 2024).
Dhanuka Agritech is one of India's leading branded crop-protection formulators, built over four decades on an asset-light model: it in-licenses or sources patented and specialty molecules from multinational innovators (principally Japanese, American and European), formulates them at owned plants in Gujarat, Rajasthan and Jammu & Kashmir, and pushes them through one of the deepest farm-gate distribution networks in Indian agrochemicals — reported at roughly 8,800 distributors/dealers and ~80,000 retailers reaching about 10 million farmers. It is a pure-play domestic agrochemical company with a herbicide-heavy kharif and insecticide/fungicide-heavy rabi seasonality, revenue of ₹2,020 Cr in FY2026 and a structurally debt-free balance sheet. Since FY2024 it has been attempting a strategic upgrade — backward integration into technical manufacturing at Dahej, acquisition of Bayer's iprovalicarb and triadimenol rights (its first international platform), and a new ₹200 Cr formulation plant at Nagpur — while navigating weather-driven volatility, a de-rated share price and margin pressure in FY2027. --- ### What the company does Dhanuka Agritech manufactures and markets agrochemicals — herbicides, insecticides, fungicides, plant growth regulators (PGRs), biologicals/biostimulants and adjuvants — in liquid, dust, powder and granule forms. The company's own business description (as carried in its annual report and reproduced in market-data profiles) characterises it as an India-based agri-input company engaged in manufacturing a wide range of agro-chemicals in these categories. Aggregator profiles (Screener, citing company disclosures) report 300+ product registrations and roughly 90 marketed products. ### Business model The company's model has three layers: 1. **Molecule access (in-licensing / partnership).** Dhanuka's historical competitive edge has been its relationships with global innovators that supply technical-grade active ingredients (or co-market new molecules) for launch in India under Section 9(3) registrations (first-time registration of a new molecule in India). Examples verified in recent disclosures include Tizom (sugarcane herbicide launched with Nissan Chemical, Japan, FY2024) and Dinkar (paddy herbicide launched with Hokko Chemical, Japan, Q1 FY2026). ICRA and CARE both cite these multinational tie-ups as a core rating strength because they support specialty pricing and margins [ICRA; CARE]. 2. **Formulation manufacturing.** Owned formulation units in Gujarat (Sanand), Rajasthan (Keshwana) and Jammu & Kashmir (Udhampur); a technical (chemical synthesis) plant at Dahej, Gujarat, commissioned in FY2024; and a planned 23,000 MTPA formulation plant at Nagpur (operational ~April 2028) [Q1FY27]. 3. **Branded B2C distribution.** Products are sold under Dhanuka brands through distributors and retailers, supported by large field-force and farmer-education activity. Management has repeatedly emphasised farmer outreach and demand generation in earnings calls. A small but rising B2B component (selling technicals/intermediates and institutional sales, increasingly linked to Dahej output and the Bayer molecules) grew from ~4% of revenue in FY2024 to ~9% in FY2025 (Q4 FY2025 earnings call summary via Sabari Securities). ### Value-chain position Dhanuka sits in the mid-to-downstream segment of the agrochemical value chain: it historically purchased technical-grade AIs and added value through formulation, branding and distribution. Dahej marks a partial move upstream (backward integration), which ICRA described as expected to provide raw-material security and to expand contribution margins [ICRA]. It does not engage in discovery-stage molecule research (no NCE discovery programme has been disclosed). ### Customer types and end-markets **Direct customers:** distributors and dealers (trade channel), with retailers as the next tier; B2B customers for technicals and the international Bayer-molecule business. **End users:** Indian farmers across field crops (paddy, soybean, cotton, maize, pulses, sugarcane, wheat) and horticulture (grapes, chilli, vegetables). Management flagged paddy, soybean, pulses, sugarcane, horticulture (especially grapes and chilli) and maize as focus crops (Q4 FY2025 call). **International end-markets (new):** 20+ countries across Latin America, EMEA and Asia for iprovalicarb (Melody brand family) and triadimenol (seed treatment), via a distributor-led global B2B model announced in January 2025. ### Independent characterisation Dhanuka is best understood as a high-ROE, low-capital-intensity domestic distribution franchise that monetises in-licensed chemistry. Its moat has been distribution depth plus a pipeline of 9(3) launches; its vulnerability is that the moat is not chemistry it owns. Two strategic shifts are underway: (a) partial vertical integration (Dahej, Nagpur) that raises fixed-asset intensity and has so far produced EBITDA losses at Dahej, and (b) ownership of acquired molecule rights (Bayer) that begins to give it proprietary IP and an international foothold. Revenue growth has been modest (≈7.8% 5-year CAGR FY2021–FY2026) and highly monsoon-sensitive, while margins have stayed in a ~16–20% EBITDA band.
3 interactive charts drawn from the Lambda-Cyhalothric Acid Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Lambda-Cyhalothric Acid Market By Purity
Global Lambda-Cyhalothric Acid Market By Downstream Product
Global Lambda-Cyhalothric Acid Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
